Phase 1, Open Label Study to Assess the Safety and Tolerability of U3-1565 in Subjects with Advanced Solid Malignant Tumors (Daiichi Pharmaceutical Corporation #U13565-A-U101)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Feb 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

28 Jul 2018 Results published in the Investigational New Drugs
16 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
11 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com